Reshape Biotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 65

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 18

Reshape Biotech General Information

Description

Developer of lab automation robots designed to digitize microbiological research workflows. The company offers automated plate imaging devices, AI-driven assay analysis, smart incubators with time-lapse imaging, and a cloud-based data platform, enabling biotech companies and research laboratories to standardize experiments and manage structured data across teams.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Østbanegade 55
  • 1st floor
  • 2100 Copenhagen
  • Denmark
+45 40
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Corporate Office
  • Østbanegade 55
  • 1st floor
  • 2100 Copenhagen
  • Denmark
+45 40

Reshape Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reshape Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 01-Dec-2025 Completed Generating Revenue
8. Later Stage VC (Series A) 09-Apr-2024 Completed Generating Revenue
7. Seed Round 09-Feb-2023 Completed Generating Revenue
6. Seed Round 27-May-2021 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
4. Grant 01-Oct-2020 Completed Startup
3. Angel (individual) 08-Jun-2020 Completed Startup
2. Accelerator/Incubator 03-Dec-2019 $21.1K Completed Startup
1. Accelerator/Incubator 01-Jan-2019 $21.1K $21.1K Completed Startup
To view Reshape Biotech’s complete valuation and funding history, request access »

Reshape Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Reshape Biotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Reshape Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reshape Biotech Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dittes Ventures Venture Capital Minority
Francis Family Fund Family Office Minority
21st.Bio VC-Backed Company Minority
Astanor Impact Investing Minority
Angel (individual) Minority
You’re viewing 5 of 18 investors. Get the full list »

Reshape Biotech FAQs

  • When was Reshape Biotech founded?

    Reshape Biotech was founded in 2018.

  • Where is Reshape Biotech headquartered?

    Reshape Biotech is headquartered in Copenhagen, Denmark.

  • What is the size of Reshape Biotech?

    Reshape Biotech has 65 total employees.

  • What industry is Reshape Biotech in?

    Reshape Biotech’s primary industry is Other Healthcare Technology Systems.

  • Is Reshape Biotech a private or public company?

    Reshape Biotech is a Private company.

  • What is Reshape Biotech’s current revenue?

    The current revenue for Reshape Biotech is .

  • How much funding has Reshape Biotech raised over time?

    Reshape Biotech has raised $29.4M.

  • Who are Reshape Biotech’s investors?

    Dittes Ventures, Francis Family Fund, 21st.Bio, Astanor, and are 5 of 18 investors who have invested in Reshape Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process